Biotech & AI drug discoverySTAT — Biotech

STAT+: Ultragenyx cuts staff after another study fails

Ultragenyx announced it is laying off about 20% of its staff as it ends development of two rare disease drugs.

AI summary · generated only from source feed metadata; consult original

Source published2026-11-04T14:46:46+00:00

Published here2026-11-04T15:42:06+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/11/04/biotech-news-ultragenyx-cuts-staff-after-another-study-fails/

Original headline

STAT+: Ultragenyx cuts staff after another study fails

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.